Skip Navigation



BJA Advance Access published online on May 16, 2007

British Journal of Anaesthesia, doi:10.1093/bja/aem125
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/2/191    most recent
aem125v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gopalakrishna, M. D.
Right arrow Articles by Shenoy, U. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gopalakrishna, M. D.
Right arrow Articles by Shenoy, U. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

The effect of ephedrine on intubating conditions and haemodynamics during rapid tracheal intubation using propofol and rocuronium

M. D. Gopalakrishna, H. M. Krishna* and U. K. Shenoy

Department of Anaesthesiology, Kasturba Medical College, Manipal 576104, India

* Corresponding author. E-mail: hmkrishna20032002{at}yahoo.com

Background: We compared the effect of pre-treatment with ephedrine 75, 100, 150 µg kg–1 and saline on intubating conditions and haemodynamics during rapid tracheal intubation using propofol and rocuronium.

Methods: One hundred adult patients randomized into one of the four groups—PE 75, PE 100, PE 150, and saline (control) groups—were pre-treated with i.v. ephedrine 75, 100, 150 µg kg–1 or saline, respectively, 1 min before rapid tracheal intubation using propofol 2.5 mg kg–1 and rocuronium 0.6 mg kg–1. A blinded anaesthesiologist assessed the intubating conditions. Heart rate and mean arterial pressure were recorded before anaesthesia induction (baseline), post-induction, and every minute after intubation for 5 min. A 20% change in haemodynamic variables from baseline was regarded as clinically significant. Data were analysed using ANOVA test with post hoc Tukey's test and {chi}2 or Fisher's exact test. P<0.05 was regarded as significant.

Results: Patient characteristics, baseline heart rate, and mean arterial pressure were comparable between the groups. Intubating conditions were significantly better in the PE 75 (P=0.003) and PE 100 (P=0.001) groups. A significant increase in heart rate was observed in the PE 75 and PE 150 groups when compared with the saline group. A statistically significant difference in mean arterial pressure was noted between PE 75 and PE 150 groups and between PE 150 and saline groups at most of the time intervals. However, when considering the clinical significance of these, all groups were comparable (P>0.05).

Conclusions: Ephedrine either 75 or 100 µg kg–1 given before rapid tracheal intubation using propofol and rocuronium bromide improves the intubation conditions. It is not effective in preventing the hypotension which follows ensuing induction of anaesthesia.

Keywords: anaesthetics i.v., propofol; haemodynamics; heart, heart rate; induction, rapid sequence; intubation, intubating conditions; mean arterial pressure; neuromuscular block, rocuronium; premedication, ephedrine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.